KR101508565B1 - Novel method for preparing itopride and the intermediate obtained from the method - Google Patents
Novel method for preparing itopride and the intermediate obtained from the method Download PDFInfo
- Publication number
- KR101508565B1 KR101508565B1 KR20080048928A KR20080048928A KR101508565B1 KR 101508565 B1 KR101508565 B1 KR 101508565B1 KR 20080048928 A KR20080048928 A KR 20080048928A KR 20080048928 A KR20080048928 A KR 20080048928A KR 101508565 B1 KR101508565 B1 KR 101508565B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- compound
- equivalents
- preparing
- itopride
- Prior art date
Links
- 0 *c1ccc(CN)cc1 Chemical compound *c1ccc(CN)cc1 0.000 description 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/46—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/65—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
Abstract
본 발명은 이토프라이드의 신규한 중간체 및 그 제조 방법 및 이를 이용한 이토프라이드의 제조방법에 관한 것이다. 본 발명의 제조방법에 의해, 안정한 벤즈아미드 유도체를 거쳐 최종 이토프라이드를 고순도 및 고수율로 얻을 수 있으며, 본 발명의 제조방법은 공정이 간단하고 제조비용이 저렴하여, 이토프라이드의 대량생산에 이용가능하다.The present invention relates to a novel intermediate of itopride, a process for preparing the same, and a process for producing itopride using the same. According to the production method of the present invention, the final itopride can be obtained in a high purity and a high yield through a stable benzamide derivative, and the production method of the present invention can be used for mass production of itopride It is possible.
이토프라이드, 소화불량, 소화기, 아미드 화합물, 제조방법 Ito Pride, Indigestion, Digestion, Amide Compound, Manufacturing Method
Description
본 발명은 이토프라이드의 신규한 중간체 및 그 제조 방법 및 이를 이용한 이토프라이드 및 염산 이토프라이드의 제조방법에 관한 것이다.The present invention relates to a novel intermediate of itopride, a process for preparing the same, and a process for preparing itopride and hydrochloride isopride using the same.
하기 화학식 1의 이토프라이드에 에탄올 및 염산을 사용하여 제조한 염산염 화합물은 일반명 염산 이토프라이드(Itopride Hydrochloride)로 기능성 소화불량으로 인한 소화기증상의 환자에게 위신경기능을 활성화하는 약물로 이용되고 있다. The hydrochloride compound prepared by using ethanol and hydrochloric acid in itopride of formula (1) is used as a drug that activates gastric function in patients suffering from gastrointestinal symptoms caused by functional dyspepsia with general hydrochloric acid Itopride hydrochloride.
이토프라이드의 제조방법에 관하여는 유럽특허 제 306827 및 대한민국 특허 출원 공개 번호 제 1989-0005036 에 기술되어 있는데, 하기 반응식 1의 제조 방법에 나타난 바와 같이, 중간체 화합물인 4-[2-(디메틸아미노)에톡시]벤질아민 (6)을 경유하여 이토프라이드를 제조한다.The preparation method of ito pride is described in European Patent No. 306827 and Korean Patent Application Publication No. 1989-0005036. As shown in the production method of the following Reaction Scheme 1, the intermediate compound 4- [2- (dimethylamino) Ethoxy] benzylamine (6).
<화학식 1>≪ Formula 1 >
상기 방법은 라니-니켈 및 초고압(50kg/㎠)의 수소를 이용하기 때문에 폭발의 위험이 있고, 메탄올에 포화된 암모니아 가스를 사용함으로써 인체와 환경에 치명적인 영향을 끼칠수도 있었고, 금속촉매인 라니-니켈을 사용함으로써 최종화합물에 중금속이 잔존할 수 있는 가능성이 있었다. 따라서 안전 장치 구비등의 높은 생산단가의 문제점이 있었다. 이에 대해 이토프라이드의 새로운 제조방법을 개발하려는 노력이 계속되어 왔으나, 합성 경로의 일부분만이 개선되어 왔으며, 전체 합성 경로를 개선한 합성 방법은 제시되지 못하였다.Since the method uses Raney-nickel and hydrogen at an ultra-high pressure (50 kg / cm 2), there is a risk of explosion, and ammonia gas saturated with methanol may be used, which may have a serious effect on the human body and the environment. There is a possibility that heavy metals may remain in the final compound by using nickel. Therefore, there is a problem of a high production cost such as a safety device. On the other hand, efforts have been made to develop a new manufacturing method of Ito Pride, but only a part of the synthesis route has been improved, and a synthesis method improving the entire synthesis route has not been proposed.
본 발명의 목적은 N-[[4-(2-디메틸아미노에톡시)페닐]메틸]-3,4-디메톡시벤즈아미드 (이하, 이토프라이드)의 신규한 제조 방법을 제공하는 것이며, 또한 신규의 중간체 화합물을 제공하는 것이다. 즉 간단한 제조공정에 의해 최종 이토프라이드를 고순도 및 고수율로 얻음으로써 저렴한 비용으로 이토프라이드를 대량생산 할 수 있는 제조 방법 및 중간체를 제공하는 것이다. An object of the present invention is to provide a novel process for producing N - [[4- (2-dimethylaminoethoxy) phenyl] methyl] -3,4-dimethoxybenzamide (hereinafter referred to as itopride) ≪ / RTI > That is, it is an object of the present invention to provide a production method and an intermediate product capable of mass-producing itopride at a low cost by obtaining a final itopride in a high purity and a high yield by a simple manufacturing process.
본 발명은 이토프라이드 및 염산 이토프라이드의 신규한 제조 방법을 제공하고, 신규의 중간체 화합물을 제공한다.The present invention provides a novel process for preparing itopride and hydrochloride itopride, and provides novel intermediate compounds.
본 발명의 제조 방법은, 상기 화학식 1의 이토프라이드를 제조하는 데에 유용한 중간체 물질인 하기 화학식 4의 안정한 벤즈아미드 화합물을 제조하는 단계를 거쳐 이토프라이드 및 염산 이토프라이드를 제조한다.The preparation process of the present invention produces itopride and its hydrochloride isopride through a step of preparing a stable benzamide compound represented by the following formula (4), which is an intermediate material useful for preparing the itopride of the formula (1).
<화학식 4>≪ Formula 4 >
R2: F, Cl, Br, I, OMs, OTs 또는 OP=O(OR4)₂R2: F, Cl, Br, I, OMs, OTs or OP = O (OR4)
R4: 탄소수 1 내지 4의 알킬R4: alkyl having 1 to 4 carbon atoms
이때, OMs 는 메탄 설포네이트At this time, the OMs are methane sulfonate
, ,
OTs 는 4-메틸 벤젠 설포네이트OTs is 4-methylbenzenesulfonate
OP=O(OR4)₂는 디-알킬 포스페이트OP = O (OR < 4 >) 2 is di-alkyl phosphate
이다.to be.
상기 화학식 4의 화합물을 제조하는 방법은 하기의 단계를 포함한다: The method for preparing the compound of formula (4) comprises the following steps:
하기 화학식 2의 화합물 및 하기 화학식 3의 화합물을 출발물질로 하여, 화학식 2의 R1이 하이드록시기 인 경우 치환반응 아미드화 반응(amide condensation)에 의해, 그리고 R1이 F, Cl, Br, 또는 I인 경우 아미드화 반응에 의해 화학식 4의 화합물을 제조하는 단계, 이때 바람직하게는 에틸아세테이트, 디클로로메탄 또는 테트라하이드로퓨란으로 이루어지는 군으로부터 선택되는 반응용매를 사용한다; 및Wherein R 1 in the formula (2) is a hydroxyl group, by amide condensation, and R 1 is a group selected from the group consisting of F, Cl, Br, Or I, a compound of formula 4 is prepared by an amidation reaction, preferably using a reaction solvent selected from the group consisting of ethyl acetate, dichloromethane or tetrahydrofuran; And
클로로포름, 디클로로메탄, 에틸아세테이트, 프로필아세테이트, 이소프로필아세테이트, 부틸아세테이트 및 t-부틸아세테이트로 이루어지는 군으로부터 선택되는 용매로 추출하는 단계.Extraction with a solvent selected from the group consisting of chloroform, dichloromethane, ethyl acetate, propyl acetate, isopropyl acetate, butyl acetate and t-butyl acetate.
<화학식 2>(2)
R1: OH, F, Cl, Br, 또는 I R 1 : OH, F, Cl, Br, or I
<화학식 3>(3)
R2: F, Cl, Br, I, OMs, OTs 또는 OP=O(OR4)₂R2: F, Cl, Br, I, OMs, OTs or OP = O (OR4)
R4: 탄소수 1 내지 4의 알킬R4: alkyl having 1 to 4 carbon atoms
<화학식 4>≪ Formula 4 >
R2: F, Cl, Br, I, OMs, OTs 또는 OP=O(OR4)₂R2: F, Cl, Br, I, OMs, OTs or OP = O (OR4)
R4: 탄소수 1 내지 4의 알킬R4: alkyl having 1 to 4 carbon atoms
하나의 구현예에서, 상기 화학식 2의 화합물의 R1이 F, Cl, Br, 또는 I이고, 바람직하게는, 트리에틸아민 2.0 내지 3.0 당량의 존재하에서 상기 화학식 2의 화합물 1.0 당량에 대하여 상기 화학식 3의 화합물 1.0 내지 1.5 당량을 20 내지 50℃에서 교반시키는 것을 포함하여 상기 화학식 4의 화합물을 생성한다.In one embodiment, R 1 of the compound of Formula 2 is F, Cl, Br, or I, preferably, in the presence of 2.0 to 3.0 equivalents of triethylamine, with respect to 1.0 equivalent of the compound of Formula 2, 3 with 1.0 to 1.5 equivalents of the compound of Formula 4 at 20 to 50 < 0 > C.
또 하나의 구현예에서, 화학식 4의 화합물을 제조하는 단계는, R1이 하이드록시기이고, 치환 반응으로 화학식 2의 화합물 1.0 당량에 대하여 NHSu(N-HydroxySuccinimide) 1.0 내지 1.2 당량과 DCC(N,N'-Dicyclohexylcarbodiimide) 1.0 내지 1.2 당량을 0℃ 이하에서 교반시키고, 아미드화 반응으로 화학식 2의 화합물 1.0 당량에 대하여 상기 화학식 3의 화합물 1.0 내지 1.5 당량과 트리에틸아민 군 2.0 내지 5.0 당량을 투입하여 0 내지 50℃에서 교반시키는 것을 특징으로 한다. In another embodiment, the step of preparing the compound of formula (4) is a process wherein R 1 is a hydroxyl group and 1.0 to 1.2 equivalents of NHSu (N-HydroxySuccinimide) and 1.0 to 1.2 equivalents of DCC , N'-Dicyclohexylcarbodiimide) is stirred at 0 ° C or lower, and 1.0 to 1.5 equivalents of the compound of the formula 3 and 2.0 to 5.0 equivalents of the triethylamine group are added to 1.0 equivalent of the compound of the formula 2 by the amidation reaction Followed by stirring at 0 to 50 ° C.
이때, 상기 치환 반응은 하기와 같이 수행될 수도 있다:At this time, the substitution reaction may be carried out as follows:
화학식 2의 화합물 1.0 당량에 대하여 HoBT(1-HydroxyBenzotriazole) 1.0 내지 1.2 당량과 EDC(1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride) 1.0 내지 1.2 당량을 0℃ 이하에서 교반시킴;1.0 to 1.2 equivalents of HoBT (1-HydroxyBenzotriazole) and 1.0 to 1.2 equivalents of EDC (1-Ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride) are added to 1.0 equivalent of the compound of Formula 2 at 0 ° C or less;
화학식 2의 화합물 1.0 당량에 대하여 HATU(O-(7-Azabenzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate) 1.0 내지 1.2 당량을 0℃ 이하에서 교반시킴; 또는1.0 to 1.2 equivalents of HATU (O- (7-Azabenzotriazol-1-yl) -N, N, N ', N'-tetramethyluronium hexafluorophosphate) is added to 1.0 equivalents of the compound of formula or
화학식 2의 화합물 1.0 당량에 대하여 DMAP(4-(Dimethylamino)pyridine) 1.0 내지 1.2 당량과 DIC(N,N'-Diisopropylcarbodiimide) 1.0 내지 1.2 당량을 0℃ 이하에서 교반시킴.1.0 to 1.2 equivalents of DMAP (4- (Dimethylamino) pyridine) and 1.0 to 1.2 equivalents of DIC (N, N'-Diisopropylcarbodiimide) are stirred at 0 占 폚 or less with respect to 1.0 equivalent of the compound of Formula 2.
본 발명은 또한 이렇게 만들어진 화학식 4의 화합물을 중간체로 사용하여 이토프라이드를 제공하는 방법을 제공한다.The present invention also provides a method for providing itopride using the compound of formula 4 thus prepared as an intermediate.
하나의 구현예에서, 화학식 4의 화합물과 화학식 5의 화합물을 치환반응을 통한 커플링에 의해 이토프라이드를 제조하는 제조 방법으로서, 이때 화학식 4의 R2가 OMs, OTs 또는 OP=O(OR4)₂인 경우 화학식 5의 R3은 하이드록시기 또는 NaO 이고 화학식 4의 R2가 F, Cl, Br, 또는 I인 경우 화학식 5의 R3가 하이드록시기 인 것을 특징으로 한다.In one embodiment, there is provided a process for preparing itopride by coupling a compound of formula (4) and a compound of formula (5) via a substitution reaction wherein R 2 of formula (4) is OMs, OTs or OP = O ₂, R 3 in Chemical Formula 5 is a hydroxyl group or NaO, and R 2 in Chemical Formula 4 is F, Cl, Br, or I, R 3 in Chemical Formula 5 is a hydroxyl group.
<화학식 4>≪ Formula 4 >
R2: F, Cl, Br, I, OMs, OTs 또는 OP=O(OR4)₂R2: F, Cl, Br, I, OMs, OTs or OP = O (OR4)
R4: 탄소수 1 내지 4의 알킬R4: alkyl having 1 to 4 carbon atoms
<화학식 5>≪ Formula 5 >
R3: OH 또는 NaOR 3 : OH or NaO
바람직하게는, 상기 화학식 4의 화합물로부터 선택되는 염기 4.0 ~ 15.0 당량의 존재하에서 화학식 4의 화합물 1.0 당량에 대하여 상기 화학식 5의 화합물 1.0 ~ 6.0 당량을 투입 후 실온에서 교반시키는 단계를 포함하고, 이때, 사용되는 용매의 예로서는 톨루엔, DMF, 에틸알코올, 메틸알코올 또는 이소프로필알코올 등이 있다. 톨루엔 또는 DMF가 용매로 사용된 경우, 교반후 100 ~ 140℃에서 환류냉각하는 단계를 더 포함할 수 있고, 에틸알코올, 메틸알코올 또는 이소프로필알코올 등의 알코올이 용매로 사용된 경우에는 교반후 60 ~ 85℃에서 환류냉각시키는 것을 포함할 수 있다.Preferably, 1.0 to 6.0 equivalents of the compound of the formula (5) is added to 1.0 equivalent of the compound of the formula (4) in the presence of 4.0 to 15.0 equivalents of a base selected from the compound of the formula (4), followed by stirring at room temperature , And examples of the solvent to be used include toluene, DMF, ethyl alcohol, methyl alcohol or isopropyl alcohol. When toluene or DMF is used as a solvent, the reaction may further include reflux cooling at 100 to 140 ° C after stirring, and when alcohol such as ethyl alcohol, methyl alcohol or isopropyl alcohol is used as a solvent, RTI ID = 0.0 > 85 C < / RTI >
상기 제조방법의 하나의 구현예가 하기 반응식 2에 도시된다. 하기 반응식 2를 상세하게 설명하면, 본 발명은 화학식 2 및 화학식 3의 화합물을 반응시켜 화학식 4의 중간체를 제조한다. 이후 화학식 5의 화합물과의 치환반응을 통하여 이토프라이드를 합성한다.One embodiment of the above process is shown in Scheme 2 below. The present invention relates to a process for preparing an intermediate of formula (4) by reacting a compound represented by formula (2) and (3). Then, the itopride is synthesized through a substitution reaction with the compound of the formula (5).
상기 제조방법의 구체적인 구현예가 하기 반응식 3 및 4에 도시된다.Specific examples of the preparation method are shown in the following Reaction Schemes 3 and 4.
(상기에서 OMs 대신 OTs를 이용한 경우도 동일하다)(The same applies to the case where OTs is used instead of OMs in the above description)
(상기에서 F 위치가 Br, Cl, I인 화합물의 경우에도 동일하다)(The same applies to the case where the F position is Br, Cl, I)
본 발명은 또한 상기 제조된 이토프라이드에 염산을 이용하여 하기 화학식 6의 염산 이토프라이드를 제공하는 방법을 제공한다.The present invention also provides a method for providing the above-prepared itopride with hydrochloric acid to give the hydrochlorofluorocarbons.
<화학식 6>(6)
이하 본 발명은 하기 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 보다 구체적으로 설명하는 것일 뿐이며 본 발명의 범위를 실시예에 제한하는 것은 아니다.Hereinafter, the present invention will be described in detail with reference to the following examples. However, the following examples are intended to illustrate the present invention in more detail and are not intended to limit the scope of the present invention.
[실시예 1][Example 1]
출발물질 (화학식 3의 화합물)의 제조 IPreparation of the starting material (compound of formula 3) I
4-하이드록시벤조니트릴(4-hydroxybenzonitrile) 11.91g(0.10 mol)을 디클로로메탄 110.91ml에 녹이고, 트리에틸아민(Triethylamine) 13.16g(0.13 mol)을 투입하였다. 30분 동안 교반하고 메탄술포닐 클로라이드(Methansulfonyl chloride) 13.75g(0.12 mol)을 적가 하였다. 이 혼합액을 1시간동안 교반하였다. 1시간 후 물 200ml를 투입하고 30분 동안 교반하였다. 이 혼합액을 분리하여, 디클로로메탄층만 취하여 무수황산마그네슘 1.2g를 투입한 후 여과하였다. 여과액을 감압 증류하여 노말헥산 119.1ml를 투입하였다. 침전된 화합물을 여과하고 감압 건조하여 목적화합물 19.45g(수율 98.6%)을 얻었다.11.91 g (0.10 mol) of 4-hydroxybenzonitrile was dissolved in 110.91 ml of dichloromethane, and 13.16 g (0.13 mol) of triethylamine was added thereto. Stirred for 30 minutes and added dropwise with 13.75 g (0.12 mol) of methanesulfonyl chloride. This mixture was stirred for 1 hour. After 1 hour, 200 ml of water was added and stirred for 30 minutes. The mixed solution was separated, and only dichloromethane layer was taken, and 1.2 g of anhydrous magnesium sulfate was added thereto, followed by filtration. The filtrate was distilled under reduced pressure and 119.1 ml of n-hexane was added. The precipitated compound was filtered and dried under reduced pressure to obtain 19.45 g (yield: 98.6%) of the desired compound.
[실시예 2] [Example 2]
출발물질 (화학식 3의 화합물)의 제조 Preparation of the starting material (compound of formula 3) IIII
4-하이드록시벤조니트릴(4-hydroxybenzonitrile) 11.91g(0.10 mol)을 디클로로메탄 110.91ml 에 녹이고, 트리에틸아민(Triethylamine) 13.16g(0.13 mol)을 투 입하였다. 30분 동안 교반하고 4-methylbenzene-1-sulfonyl chloride 22.88g(0.12 mol)을 적가 하였다. 이 혼합액을 1시간동안 교반하였다. 1시간 후 물 200ml를 투입하고 30분 동안 교반하였다. 이 혼합액을 분리하여, 디클로로메탄층만 취하여 무수황산마그네슘 1.2g를 투입한 후 여과하였다. 여과액을 감압 증류하여 노말 헥산 119.1ml를 투입하였다. 침전된 화합물을 여과하고 감압 건조하여 목적화합물 26.62g(수율 97.4%)을 얻었다.11.91 g (0.10 mol) of 4-hydroxybenzonitrile was dissolved in 110.91 ml of dichloromethane, and 13.16 g (0.13 mol) of triethylamine was added thereto. After stirring for 30 minutes, 22.88 g (0.12 mol) of 4-methylbenzene-1-sulfonyl chloride was added dropwise. This mixture was stirred for 1 hour. After 1 hour, 200 ml of water was added and stirred for 30 minutes. The mixed solution was separated, and only dichloromethane layer was taken, and 1.2 g of anhydrous magnesium sulfate was added thereto, followed by filtration. The filtrate was distilled under reduced pressure and 119.1 ml of n-hexane was added. The precipitated compound was filtered and dried under reduced pressure to obtain 26.62 g (yield 97.4%) of the desired compound.
[실시예 3][Example 3]
출발물질 (화학식 3의 화합물)의 제조 Preparation of the starting material (compound of formula 3) IIIIII
4-시아노페닐 메탄술포네이트(4-cyanophenyl methanesulfonate) 19.45g(0.10 mol)을 에탄올 195ml를 투입하여 상온(20~25℃)에서 녹였다. 이 혼합물에 니켈 클로라이드(NiCl2) 12.83g(0.10 mol)과 붕수소나트륨 11.24g(0.30 mol)을 투입하고 30분 동안 교반하였다. 이 혼합물을 셀라이트(Celite)를 사용하여 여과하고 감압 농축하여 목적화합물 18.45g(93.11%)을 얻었다.19.45 g (0.10 mol) of 4-cyanophenyl methanesulfonate was dissolved in 195 ml of ethanol at room temperature (20 to 25 ° C). To this mixture were added 12.83 g (0.10 mol) of nickel chloride (NiCl 2 ) and 11.24 g (0.30 mol) of sodium borohydride and stirred for 30 minutes. The mixture was filtered using Celite and concentrated under reduced pressure to obtain 18.45 g (93.11%) of the title compound.
[실시예 4][Example 4]
출발물질 (화학식 3의 화합물)의 제조 Preparation of the starting material (compound of formula 3) IVIV
4-시아노페닐 메탄술포네이트(4-cyanophenyl methanesulfonate) 19.45g(0.10 mol)을 메탄올 195ml를 투입하여 상온(20~25℃)에서 녹였다. 이 혼합물에 Pd/C (Palladium on Activated Carbon) 1.95g(10% w)를 투입하고 수소가스 고압(4Bar)하에서 2시간 동안 교반하였다. 이 혼합물을 여과하고 감압 농축하여 목적화합물 17.86g(90.0%)을 얻었다.19.45 g (0.10 mol) of 4-cyanophenyl methanesulfonate was dissolved in methanol (195 ml) at room temperature (20 to 25 ° C). 1.95 g (10% w) of Pd / C (Palladium on Activated Carbon) was added to the mixture, and the mixture was stirred under a hydrogen gas pressure (4 Bar) for 2 hours. The mixture was filtered and concentrated under reduced pressure to obtain 17.86 g (90.0%) of the desired compound.
[실시예 5][Example 5]
출발물질 (화학식 3의 화합물)의 제조 VPreparation of starting material (compound of formula 3) V
4-시아노페닐 메탄술포네이트(4-cyanophenyl methanesulfonate) 19.45g(0.10 mol)을 THF 195ml를 투입하여 상온(20~25℃)에서 녹였다. 이 혼합물에 BH3 ㆍS(Me)2 9.03ml(0.12 mol)를 적가하고 2시간 동안 교반하였다. 이 혼합물을 여과하고 감압 농축하여 목적화합물 17.40g(87.5%)을 얻었다.19.45 g (0.10 mol) of 4-cyanophenyl methanesulfonate was dissolved in THF (195 ml) at room temperature (20 to 25 ° C). It was added dropwise a BH 3 and S (Me) 2 9.03ml (0.12 mol) to the mixture and stirred for 2 hours. This mixture was filtered and concentrated under reduced pressure to give the desired compound (17.40 g, 87.5%).
[실시예 6][Example 6]
중간체 (화학식 4의 화합물)의 제조 IPreparation of intermediate (compound of formula 4) I
4-(아미노메틸)페닐 메탄술포네이트(4-(aminomethyl)phenyl methanesulfonate) 19.45g(0.09 mol)을 메탄올에 녹이고 3,4-다이메톡시벤조일 클로라이드 (3,4-dimethoxybenzoyl chloride)를 17.65g(0.09 mol)을 투입하여 10분 동안 교반하였다. 이 혼합물에 트리에틸아민(Triethylamine) 36.8ml(0.26 mol)을 적가하고 2시간 동안 교반하였다. 교반 후 이 혼합물을 0℃로 냉각한 후 여과하여 목적화합물 30.51g(95.0%)를 얻었다. 1H-NMR (300MHz) C17H19NO6S δ 3.134 (s, 3H) 3.914 (s, 6H) 4.623 (d, J=6Hz, 2H) 6.547 (s, 1H) 6.853 (d, J=8.4Hz, 1H) 7.241 (d, J=8.7Hz, 2H) 7.306 (q, J=3.4Hz, 1H) 7.393 (d, J=8.4Hz, 2H) 7.447 (d, J=1.8Hz, 1H) 19.45 g (0.09 mol) of 4- (aminomethyl) phenyl methanesulfonate was dissolved in methanol, and 17.65 g (0.04 mol) of 3,4-dimethoxybenzoyl chloride 0.09 mol) was added thereto and stirred for 10 minutes. 36.8 ml (0.26 mol) of triethylamine was added dropwise to the mixture, and the mixture was stirred for 2 hours. After stirring, the mixture was cooled to 0 占 폚 and then filtered to obtain the objective compound (30.51 g, 95.0%). 1 H-NMR (300MHz) C 17 H 19 NO 6 S δ 3.134 (s, 3H) 3.914 (s, 6H) 4.623 (d, J = 6Hz, 2H) 6.547 (s, 1H) 6.853 (d, J = 8.4 (D, J = 1.8 Hz, 1H) 7.341
[실시예 7][Example 7]
중간체 (화학식 4의 화합물)의 제조 IIPreparation of intermediate (compound of formula 4) II
3,4-다이메톡시벤조익에시드(3,4-dimethxylbenzoic acid) 16.03g(0.09 mol)과 N-히드록시숙신이미드(N-hydroxysuccinimide) 12.15g(0.11 mol)를 디클로로메탄 80ml에 녹이고 -10℃ ~ 0℃에서 10분 동안 교반하였다. 이 혼합물에 디사이클로헥실카보디이미드(Dicyclohexylcarbodiimide) 21.78g(0.11 mol)를 디클로로메탄 40ml에 녹여서 적가 하였다. 이 혼합물을 2시간 동안 환류 교반하였다. 2시간 후 이 혼합물을 여과하고 여액을 감압 농축하였다. 감압 농축한 화합물에 메탄올 80ml와 4-(아미노메틸)페닐 메탄술포네이트(4-(aminomethyl)phenyl methanesulfonate) 19.45g(0.09 mol)를 투입한 후 트리에틸아민 15.47ml를 적가 하였다. 이 혼합물을 2시간동안 환류 교반하였다. 환류 교반완료 후 0℃로 냉각하여 여과하고 감압 건조하여 목적화합물 27.39g(85.3%)을 얻었다. 1H-NMR (300MHz) C17H19NO6S δ 3.134 (s, 3H) 3.914 (s, 6H) 4.623 (d, J=6Hz, 2H) 6.547 (s, 1H) 6.853 (d, J=8.4Hz, 1H) 7.241 (d, J=8.7Hz, 2H) 7.306 (q, J=3.4Hz, 1H) 7.393 (d, J=8.4Hz, 2H) 7.447 (d, J=1.8Hz, 1H) 16.03 g (0.09 mol) of 3,4-dimethoxybenzoic acid and 12.15 g (0.11 mol) of N-hydroxysuccinimide were dissolved in 80 ml of dichloromethane, And stirred at 10 ° C to 0 ° C for 10 minutes. To this mixture was added dropwise 21.78 g (0.11 mol) of dicyclohexylcarbodiimide dissolved in 40 ml of dichloromethane. This mixture was refluxed with stirring for 2 hours. After 2 hours, the mixture was filtered and the filtrate was concentrated under reduced pressure. After concentrating under reduced pressure, 80 ml of methanol and 19.45 g (0.09 mol) of 4- (aminomethyl) phenyl methanesulfonate were added, and then 15.47 ml of triethylamine was added dropwise. This mixture was refluxed with stirring for 2 hours. After completion of the reflux stirring, the mixture was cooled to 0 캜, filtered, and dried under reduced pressure to obtain 27.39 g (85.3%) of the desired compound. 1 H-NMR (300MHz) C 17 H 19 NO 6 S δ 3.134 (s, 3H) 3.914 (s, 6H) 4.623 (d, J = 6Hz, 2H) 6.547 (s, 1H) 6.853 (d, J = 8.4 (D, J = 1.8 Hz, 1H) 7.341
[실시예 8] [Example 8]
중간체 (화학식 4의 화합물)의 제조 Preparation of intermediate (compound of formula 4) IIIIII
3,4-다이메톡시벤조익에시드(3,4-dimethxylbenzoic acid) 16.03g(0.09 mol)과 N-히드록시숙신이미드(N-hydroxysuccinimide) 12.15g(0.11 mol)를 디클로로메탄 80ml에 녹이고 -10~0℃에서 10분 동안 교반하였다. 이 혼합물에 디사이클로헥실카 보디이미드(Dicyclohexylcarbodiimide) 21.78g(0.11 mol)를 디클로로메탄 40ml에 녹여서 적가 하였다. 이 혼합물을 2시간동안 환류 교반하였다. 2시간 후 이 혼합물을 여과하고 여액을 감압 농축하였다. 감압 농축한 화합물에 메탄올 80ml와 4-플루오로벤질아민(4-fluorobenzylamine) 13.77g(0.11 mol)를 투입한 후 트리에틸아민 15.47ml를 적가 하였다. 이 혼합물을 2시간동안 환류 교반하였다. 환류 교반 완료 후 0℃로 냉각하여 여과하고 여액을 감압 건조하여 목적화합물 25.07g(98.5%)을 얻었다. 1H-NMR (300MHz) C16H16FNO3 δ 3.814 (s, 3H) 3.856 (s, 3H) 4.507 (d, J=3.6Hz, 2H) 6.777 (d, J=5.1Hz, 1H) 6.945 (t, J=5.2Hz, 2H) 7.113 (s, 1H) 7.235 (t, J=4.2Hz, 2H) 7.346 (d, J=4.8Hz, 1H) 7.436 (s, 1H)16.03 g (0.09 mol) of 3,4-dimethoxybenzoic acid and 12.15 g (0.11 mol) of N-hydroxysuccinimide were dissolved in 80 ml of dichloromethane, The mixture was stirred at 10 to 0 ° C for 10 minutes. To this mixture was added dropwise 21.78 g (0.11 mol) of dicyclohexylcarbodiimide dissolved in 40 ml of dichloromethane. This mixture was refluxed with stirring for 2 hours. After 2 hours, the mixture was filtered and the filtrate was concentrated under reduced pressure. To the compound under reduced pressure, 80 ml of methanol and 13.77 g (0.11 mol) of 4-fluorobenzylamine were added, and then 15.47 ml of triethylamine was added dropwise. This mixture was refluxed with stirring for 2 hours. After completion of the reflux stirring, the mixture was cooled to 0 캜 and filtered, and the filtrate was dried under reduced pressure to obtain 25.07 g (98.5%) of the target compound. 1 H-NMR (300MHz) C 16 H 16 FNO 3 δ 3.814 (s, 3H) 3.856 (s, 3H) 4.507 (d, J = 3.6Hz, 2H) 6.777 (d, J = 5.1Hz, 1H) 6.945 ( J = 4.2 Hz, 2H), 7.346 (d, J = 4.8 Hz, 1H) 7.436 (s,
[실시예 9][Example 9]
중간체 (화학식 4의 화합물)의 제조 Preparation of intermediate (compound of formula 4) IVIV
3,4-다이메톡시벤조익에시드(3,4-dimethxylbenzoic acid) 16.03g(0.09 mol)과 N-히드록시숙신이미드(N-hydroxysuccinimide) 12.15g(0.11 mol)를 디클로로메탄 80ml에 녹이고 -10~0℃에서 10분 동안 교반하였다. 이 혼합물에 디사이클로헥실카보디이미드(Dicyclohexylcarbodiimide) 21.78g(0.11 mol)를 디클로로메탄 40ml에 녹여서 적가 하였다. 이 혼합물을 2시간 동안 환류 교반하였다. 2시간 후 이 혼합 물을 여과하고 여액을 감압 농축하였다. 감압 농축한 화합물에 메탄올 80ml와 4-클로로벤질아민(4-chlorobenzylamine) 15.30g(0.11 mol)를 투입한 후 트리에틸아민 15.47ml를 적가 하였다. 이 혼합물을 2시간동안 환류 교반하였다. 환류 교반 완료 후 0℃로 냉각하여 여과하고 여액을 감압 건조하여 목적화합물 26.77g(99.5%)을 얻었다. 1H-NMR (300MHz) C16H16ClNO3 δ 3.866 (s, 3H) 3.889 (s, 3H) 4.544 (d, J=3.3Hz, 2H) 6.812 (d, J=5.1Hz, 1H) 6.912 (s, 1H) 7.227-7.274 (m, 4H) 7.329 (d, J=5.1Hz, 1H) 7.444 (s, 1H)16.03 g (0.09 mol) of 3,4-dimethoxybenzoic acid and 12.15 g (0.11 mol) of N-hydroxysuccinimide were dissolved in 80 ml of dichloromethane, The mixture was stirred at 10 to 0 ° C for 10 minutes. To this mixture was added dropwise 21.78 g (0.11 mol) of dicyclohexylcarbodiimide dissolved in 40 ml of dichloromethane. This mixture was refluxed with stirring for 2 hours. After 2 hours, the mixture was filtered and the filtrate was concentrated under reduced pressure. To the compound under reduced pressure, 80 ml of methanol and 15.30 g (0.11 mol) of 4-chlorobenzylamine were added, and then 15.47 ml of triethylamine was added dropwise. This mixture was refluxed with stirring for 2 hours. After completion of the reflux stirring, the mixture was cooled to 0 ° C and filtered, and the filtrate was dried under reduced pressure to obtain 26.77g (99.5%) of the target compound. 1 H-NMR (300MHz) C 16 H 16 ClNO 3 δ 3.866 (s, 3H) 3.889 (s, 3H) 4.544 (d, J = 3.3Hz, 2H) 6.812 (d, J = 5.1Hz, 1H) 6.912 ( (s, 1 H) 7.227 - 7.274 (m, 4 H) 7.329 (d, J = 5.1 Hz,
[실시예 10][Example 10]
이토프라이드의Ito pride 제조 I Manufacturing I
2-(dimethylamino)ethanol 9.20ml(0.09 mol)과 수산화나트륨 7.26g(0.18 mol)를 톨루엔 300ml에 용해하고 30분 동안 환류 교반하였다. 이 혼합물에 4-((3,4-dimethoxybenzamido)methyl)phenyl methanesulfonate 30.51g(0.08 mol)를 투입하고 1시간 30분 동안 환류 교반하였다. 이 혼합물을 상온(20~25℃)로 냉각시키고 여과 후 감압 농축하였다. 이 혼합물에 디클로로메탄 600ml와 정제수 300ml를 투입하고 층분리하였다. 디클로로메탄층을 분리하여 1N HCl 수용액 450ml를 투입하여 층분리하였다. 1N HCl 수용액 층을 디클로로메탄 600ml와 3N NaOH 수용액 225ml 를 투입하여 층분리하였다. 유기층을 감압농축하고 초산에테르와 헥산을 사용하여 결정화하여 목적화합물을 23.94g(80.0%)을 수득하였다9.20 ml (0.09 mol) of 2- (dimethylamino) ethanol and 7.26 g (0.18 mol) of sodium hydroxide were dissolved in 300 ml of toluene and stirred under reflux for 30 minutes. To this mixture was added 30.51 g (0.08 mol) of 4 - ((3,4-dimethoxybenzamido) methyl) phenyl methanesulfonate and the mixture was refluxed for 1 hour and 30 minutes. The mixture was cooled to room temperature (20 to 25 ° C), filtered and concentrated under reduced pressure. To this mixture were added 600 ml of dichloromethane and 300 ml of purified water and the layers were separated. The dichloromethane layer was separated and 450 ml of 1 N HCl aqueous solution was added to separate the layers. The aqueous 1 N HCl solution was separated into layers by adding 600 ml of dichloromethane and 225 ml of 3N aqueous NaOH. The organic layer was concentrated under reduced pressure and crystallized using acetic acid ether and hexane to obtain 23.94 g (80.0%) of the target compound
[실시예 11] [Example 11]
이토프라이드의Ito pride 제조 Produce IIII
sodium 2-(dimethylamino)ethanolate 10.0g(0.09 mol), 4-((3,4-dimethoxybenzamido)methyl)phenyl methanesulfonate 30.51g(0.08 mol)과 수산화나트륨 7.26g(0.18 mol)를 디메틸포름아미드 300ml에 용해하고 1시간 30분 동안 환류 교반하였다. 이 혼합물을 상온(20~25℃)으로 냉각시키고 여과 후 감압 농축하였다. 이 혼합물에 디클로로메탄 600ml와 정제수 300ml를 투입하고 층분리하였다. 디클로로메탄층을 분리하여 1N HCl 수용액 450ml를 투입하여 층분리하였다. 1N HCl 수용액 층을 디클로로메탄 600ml와 3N NaOH 수용액 225ml를 투입하여 층분리하였다. 유기층을 감압농축하고 초산에테르와 헥산을 사용하여 결정화하여 목적화합물을 23.94g(80.0%)을 수득하였다. 30.0 g (0.08 mol) of sodium 2- (dimethylamino) ethanolate and 30.51 g (0.08 mol) of 4 - ((3,4-dimethoxybenzamido) methyl) phenyl methanesulfonate were dissolved in 300 ml of dimethylformamide And the mixture was refluxed for 1 hour and 30 minutes. The mixture was cooled to room temperature (20 to 25 DEG C), filtered and concentrated under reduced pressure. To this mixture were added 600 ml of dichloromethane and 300 ml of purified water and the layers were separated. The dichloromethane layer was separated and 450 ml of 1 N HCl aqueous solution was added to separate the layers. The aqueous 1 N HCl solution was separated into layers by adding 600 ml of dichloromethane and 225 ml of 3N aqueous NaOH. The organic layer was concentrated under reduced pressure and crystallized using acetic acid ether and hexane to obtain 23.94 g (80.0%) of the target compound.
[실시예 12] [Example 12]
이토프라이드의 제조 IIIManufacture of Ito Pride III
N-(4-chlorobenzyl)-3,4-dimethoxybenzamide 3.05g(0.01 mol), sodium 2-(dimethylamino)ethanolate 1.66g(0.015 mol)과 CuBr 0.14g(0.001 mol)을 N-메틸피롤리돈 50ml 에 용해시키고 2시간동안 환류 교반하였다. 이 혼합물을 상온으로 (20~25℃)으로 냉각시키고 여과 후 감압농축하였다. 이 혼합물에 디클로로메탄 60ml와 정제수 30ml를 투입하고 층분리하였다. 디클로로메탄층을 분리하여 1N HCl 수용액 45ml를 투입하여 층분리하였다. 1N HCl 수용액 층을 디클로로메탄 60ml와 3N NaOH 수용액 23ml를 투입하여 층분리하였다. 유기층을 감압농축하고 초산에테르와 헥산을 사용하여 결정화하여 목적화합물을 0.72g(20.0%)을 수득하였다. 1.66 g (0.015 mol) of sodium 2- (dimethylamino) ethanolate and 0.14 g (0.001 mol) of CuBr were dissolved in 50 ml of N-methylpyrrolidone, 3.05 g (0.01 mol) of N- (4-chlorobenzyl) -3,4- Dissolved and refluxed for 2 hours. The mixture was cooled to room temperature (20 to 25 DEG C), filtered and concentrated under reduced pressure. 60 ml of dichloromethane and 30 ml of purified water were added to the mixture and the layers were separated. The dichloromethane layer was separated, and 45 ml of 1 N HCl aqueous solution was added to separate the layers. The 1N HCl aqueous layer was separated into layers by adding 60 ml of dichloromethane and 23 ml of 3N aqueous NaOH. The organic layer was concentrated under reduced pressure and crystallized using acetic acid ether and hexane to obtain 0.72 g (20.0%) of the target compound.
[실시예 13][Example 13]
염산 이토프라이드의 제조Preparation of hydrochloric acid itopride
상기 실시예 11 또는 12에서 수득한 N-[[4-(2-디메틸아미노에톡시)페닐]메틸]-3,4-디메톡시벤즈아미드(이토프라이드) 23.94g을 디클로로메탄(239.4)ml에 녹이고 HCl 20ml와 활성탄 3.05g을 투입하고 30분 동안 교반하고 여과하였다. 여과한 여액을 감압농축하고 메탄올과 이소프로필 알코올 혼합용매로 결정화하여 목적화합 물 25.06g(95%)을 얻었다.23.94 g of N - [[4- (2-dimethylaminoethoxy) phenyl] methyl] -3,4-dimethoxybenzamide (itopride) obtained in Example 11 or 12 was dissolved in dichloromethane And 20 ml of HCl and 3.05 g of activated carbon were added thereto. The mixture was stirred for 30 minutes and filtered. The filtrate was concentrated under reduced pressure and crystallized with a mixed solvent of methanol and isopropyl alcohol to obtain 25.06 g (95%) of the desired compound.
본 발명은 이토프라이드 제조의 주요중간체 및 최종 이토프라이드의 제조방법을 제공함으로써 이토프라이드를 기존의 방법보다 수율이 높고 폭발위험과 환경오염 없이 경제성 높게 제조할 수 있다.The present invention provides a main intermediate for the preparation of itopride and a method for producing the final itopride, so that the itopride can be produced at a higher yield than the conventional methods, and at a higher cost without explosion risk and environmental pollution.
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20080048928A KR101508565B1 (en) | 2008-05-27 | 2008-05-27 | Novel method for preparing itopride and the intermediate obtained from the method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20080048928A KR101508565B1 (en) | 2008-05-27 | 2008-05-27 | Novel method for preparing itopride and the intermediate obtained from the method |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20090123047A KR20090123047A (en) | 2009-12-02 |
KR101508565B1 true KR101508565B1 (en) | 2015-04-03 |
Family
ID=41685338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR20080048928A KR101508565B1 (en) | 2008-05-27 | 2008-05-27 | Novel method for preparing itopride and the intermediate obtained from the method |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101508565B1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101967103A (en) * | 2010-09-28 | 2011-02-09 | 浙江金伯士药业有限公司 | Novel preparation method of itopride intermediate body |
CN106748862A (en) * | 2016-12-07 | 2017-05-31 | 江苏工程职业技术学院 | A kind of preparation method for promoting gastroenteritic power medicine Itopride Hydrochloride |
KR102638538B1 (en) * | 2021-12-28 | 2024-02-20 | 주식회사 한서켐 | New process for preparing intermediate of urapidil |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006011696A1 (en) | 2004-07-28 | 2006-02-02 | Il Yang Pharm. Co., Ltd | Method for preparing 4-[2-(dimethylamino)ethoxy]benzylamine as itopride hydrocloride salt mediate |
WO2006051079A1 (en) | 2004-11-12 | 2006-05-18 | Erregierre S.P.A. | Process for preparing itopride hydrochloride |
KR100663167B1 (en) | 2005-10-27 | 2007-01-02 | 동우신테크 주식회사 | Process for preparing itopride hydrochloride |
KR100836528B1 (en) | 2007-07-25 | 2008-06-10 | 주식회사 휴온스 | Process of manufacturing itopride hydrochloride |
-
2008
- 2008-05-27 KR KR20080048928A patent/KR101508565B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006011696A1 (en) | 2004-07-28 | 2006-02-02 | Il Yang Pharm. Co., Ltd | Method for preparing 4-[2-(dimethylamino)ethoxy]benzylamine as itopride hydrocloride salt mediate |
WO2006051079A1 (en) | 2004-11-12 | 2006-05-18 | Erregierre S.P.A. | Process for preparing itopride hydrochloride |
KR100663167B1 (en) | 2005-10-27 | 2007-01-02 | 동우신테크 주식회사 | Process for preparing itopride hydrochloride |
KR100836528B1 (en) | 2007-07-25 | 2008-06-10 | 주식회사 휴온스 | Process of manufacturing itopride hydrochloride |
Also Published As
Publication number | Publication date |
---|---|
KR20090123047A (en) | 2009-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2015324111B2 (en) | Processes and intermediates in the preparation of C5aR antagonists | |
JP2013505259A5 (en) | ||
US8940908B2 (en) | Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same | |
KR101378984B1 (en) | Production method of intermediate compound for synthesizing medicament | |
KR101508565B1 (en) | Novel method for preparing itopride and the intermediate obtained from the method | |
CN101735198A (en) | Novel method for preparing c-Met inhibitor PF22341066 | |
JP2012531407A (en) | Method for producing tricyclic derivative | |
KR20100116644A (en) | Method for preparing combretastatin | |
WO2011156355A1 (en) | Production method of phenyl guanidine salts and their intermediates | |
CN101857549B (en) | Synthetic method of (1S)-4,5-dimethoxy-1-(aminomethyl)benzocyclobutane | |
CN107001250B (en) | A method of Ao Dangka is prepared for intermediate | |
JP2024503855A (en) | Method for synthesizing aminopyrimidine-based FAK inhibitor compounds | |
JP5478508B2 (en) | Process for producing trans- {4-[(alkylamino) methyl] cyclohexyl} acetate | |
CN112830890A (en) | Preparation method of lefenacin intermediate and lefenacin | |
US20110313196A1 (en) | Novel process | |
WO2022083728A1 (en) | Intermediate of pregabalin and preparation method therefor | |
CN108395421B (en) | Preparation method of 3-amino-5-hydroxy-tetrahydropyran and salt thereof | |
US20070149606A1 (en) | Process for producing phenylacetic acid derivative | |
JP4788049B2 (en) | Dicarboxylic acid diester derivative and method for producing the same | |
KR101695346B1 (en) | Process for the preparation of ibodutant (MEN15596) and related intermediates | |
WO2013054273A2 (en) | Process for the preparation of agomelatine | |
KR20020066476A (en) | Preparation of peptide derivatives | |
TW201943707A (en) | Methods for preparing substituted dihydroindene-4-carboxamide compounds | |
CN108148044A (en) | The method that amides compound and the compound prepare Vonoprazan fumarate | |
JP2006282656A (en) | Gelling agent for functional molecule |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
FPAY | Annual fee payment |
Payment date: 20180223 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20190214 Year of fee payment: 5 |